Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Lags Revenue Estimates

Ascend Wellness Holdings (AAWH) reported a wider-than-expected loss of $0.13 per share for the quarter ended September 2025, missing the Zacks Consensus Estimate of a $0.10 loss by 30%. The company also posted revenues of $124.73 million, falling short of consensus estimates by 3.18% and representing a year-over-year decline from $141.65 million. This marks a continuation of AAWH consistently missing both EPS and revenue estimates over recent quarters, despite the stock's significant 55.1% year-to-date outperformance against the S&P 500. The current Zacks Rank for AAWH is a #3 (Hold), indicating an expectation of market-aligned performance going forward.

Analysis

Ascend Wellness Holdings (AAWH) reported a Q3 2025 loss of $0.13 per share, significantly wider than the Zacks Consensus Estimate of a $0.10 loss, representing a 30% negative surprise. Quarterly revenues of $124.73 million also missed consensus by 3.18% and declined year-over-year from $141.65 million. This marks a concerning trend, as the company has consistently failed to meet both EPS and revenue estimates over the last four quarters.

Despite these operational shortfalls, AAWH shares have demonstrated robust market outperformance, gaining 55.1% year-to-date against the S&P 500's 14.4%. The sustainability of this price movement is contingent upon management's forward-looking commentary during the upcoming earnings call, which will be critical for investor sentiment.

The stock currently holds a Zacks Rank #3 (Hold), suggesting expectations for performance in line with the broader market in the near term. While the Medical Services industry, to which AAWH belongs, is favorably positioned within the top 38% of Zacks industries, AAWH's individual financial misses warrant careful consideration.

Key Decisions for Investors

• Monitor management's commentary on the earnings call for insights into future guidance and operational strategies, given the persistent earnings and revenue misses.
• Re-evaluate AAWH's investment thesis, considering the Zacks Rank #3 (Hold) which suggests market-aligned performance, and potential negative revisions to future earnings estimates.
• Assess the sustainability of the stock's 55.1% year-to-date gain in contrast to its fundamental underperformance, particularly its consistent misses on consensus estimates.